Avicena: The Leader in Creatine Supplementation

Avicena has spearheaded extensive research on creatine and its impact on human health and is regarded as the healthcare industry's leading expert in these areas.

Through several years of collaboration and joint research with some of the country's most prestigious institutions, Avicena has gained a proprietary and in-depth understanding of the body's creatine kinase (CK) enzyme system. This has cemented the company's industry leadership position while providing Avicena with a strong and broad patent portfolio in this area.

Avicena is able to effectively enhance the production and delivery of optimal levels of energy to the brain and body through creatine supplementation in order to:

  • Promote Proper Neuron Function in the Brain
  • Support Muscle Control and Motor Function
  • Improve Quality of Life

Avicena has applied this expertise to the development of Neotine®, its proprietary creatine-based nutritional supplement.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.